INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 103 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,171,000 | +135.6% | 253,461 | +78.4% | 0.00% | – |
Q4 2018 | $497,000 | -87.7% | 142,047 | -64.7% | 0.00% | -100.0% |
Q3 2018 | $4,056,000 | -27.9% | 402,400 | -48.2% | 0.00% | 0.0% |
Q2 2018 | $5,626,000 | +43.7% | 777,057 | +19.9% | 0.00% | +100.0% |
Q1 2018 | $3,915,000 | -20.1% | 648,169 | +27.3% | 0.00% | 0.0% |
Q4 2017 | $4,899,000 | +17.8% | 509,208 | +8.7% | 0.00% | -50.0% |
Q3 2017 | $4,159,000 | -35.5% | 468,400 | -8.1% | 0.00% | -33.3% |
Q2 2017 | $6,445,000 | +19.2% | 509,412 | -1.0% | 0.00% | 0.0% |
Q1 2017 | $5,409,000 | +1.4% | 514,600 | -11.2% | 0.00% | 0.0% |
Q4 2016 | $5,334,000 | +1.3% | 579,823 | +29.8% | 0.00% | 0.0% |
Q3 2016 | $5,266,000 | -12.7% | 446,700 | -4.1% | 0.00% | -25.0% |
Q2 2016 | $6,030,000 | -42.4% | 466,027 | -28.8% | 0.00% | -20.0% |
Q1 2016 | $10,471,000 | -36.4% | 654,797 | +13.8% | 0.01% | -37.5% |
Q4 2015 | $16,471,000 | +10.2% | 575,300 | +9.6% | 0.01% | +14.3% |
Q3 2015 | $14,943,000 | -42.0% | 525,037 | -26.9% | 0.01% | -30.0% |
Q2 2015 | $25,782,000 | +190.3% | 717,774 | +369.7% | 0.01% | +150.0% |
Q1 2015 | $8,882,000 | +10.0% | 152,800 | -20.3% | 0.00% | +33.3% |
Q4 2014 | $8,078,000 | -39.7% | 191,600 | -44.5% | 0.00% | -40.0% |
Q3 2014 | $13,392,000 | +131.2% | 345,343 | +86.2% | 0.01% | +66.7% |
Q2 2014 | $5,793,000 | +18.3% | 185,493 | +56.9% | 0.00% | +50.0% |
Q1 2014 | $4,897,000 | +208.6% | 118,200 | +188.3% | 0.00% | – |
Q4 2013 | $1,587,000 | – | 41,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |